Insiders / venBio Global Strategic Fund III, L.P.
venBio Global Strategic Fund III, L.P.
CIK 1739920unknownbeneficial ownerinsider
Companies
4
First seen
Feb 19, 2021
Last activity
May 15, 2025
Companies
| Company | Shares held | Latest |
|---|---|---|
| RayzeBio, Inc. · RYZB | 5,158,162 | — |
| Ventyx Biosciences, Inc. · VTYX | 5,011,536 | — |
| Artiva Biotherapeutics, Inc. · ARTV | 1,936,637 | — |
| Elevation Oncology, Inc. · ELEV | 1,905,430 | — |
All securities held
5 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Artiva Biotherapeutics, Inc. | Common stock | 1,936,637 |
| Elevation Oncology, Inc. | Common stock | 1,905,430 |
| RayzeBio, Inc. | Common stock | 5,158,162 |
| Ventyx Biosciences, Inc. | Common stock | 5,011,536 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Ventyx Biosciences, Inc. | Options | 13,301 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 29, 2021 | Buy Open-market buy | ELEV Elevation Oncology, Inc. Common Stock | $10.00M | +625K +31.52% | 2,608,167 | high |
| Oct 25, 2021 | Buy Open-market buy | VTYX Ventyx Biosciences, Inc. Common Stock | $5.00M | +313K +8.48% | 3,997,269 5.60% of shares | high |
| Jul 22, 2024 | Buy Open-market buy | ARTV Artiva Biotherapeutics, Inc. Common Stock |